180 related articles for article (PubMed ID: 24362047)
1. A multibiomarker risk score helps predict risk for Barrett's esophagus.
Thrift AP; Garcia JM; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1267-71. PubMed ID: 24362047
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.
Thomas SJ; Almers L; Schneider J; Graham JE; Havel PJ; Corley DA
Dig Dis Sci; 2016 Jan; 61(1):70-9. PubMed ID: 26396004
[TBL] [Abstract][Full Text] [Related]
3. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.
Rubenstein JH; Morgenstern H; McConell D; Scheiman JM; Schoenfeld P; Appelman H; McMahon LF; Kao JY; Metko V; Zhang M; Inadomi JM
Gastroenterology; 2013 Dec; 145(6):1237-44.e1-5. PubMed ID: 23999171
[TBL] [Abstract][Full Text] [Related]
4. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.
Garcia JM; Splenser AE; Kramer J; Alsarraj A; Fitzgerald S; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):229-238.e3. PubMed ID: 23954649
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Barrett's esophagus among men.
Rubenstein JH; Morgenstern H; Appelman H; Scheiman J; Schoenfeld P; McMahon LF; Metko V; Near E; Kellenberg J; Kalish T; Inadomi JM
Am J Gastroenterol; 2013 Mar; 108(3):353-62. PubMed ID: 23318485
[TBL] [Abstract][Full Text] [Related]
6. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms.
Rubenstein JH; Inadomi JM; Scheiman J; Schoenfeld P; Appelman H; Zhang M; Metko V; Kao JY
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):239-45. PubMed ID: 23988686
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus.
Wang SE; Dashti SG; Hodge AM; Dixon-Suen SC; Castaño-Rodríguez N; Thomas RJS; Giles GG; Milne RL; Boussioutas A; Kendall BJ; English DR
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1630-1637. PubMed ID: 35654416
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus in Latinos undergoing endoscopy for gastroesophageal reflux disease symptoms.
Keyashian K; Hua V; Narsinh K; Kline M; Chandrasoma PT; Kim JJ
Dis Esophagus; 2013 Jan; 26(1):44-9. PubMed ID: 22332868
[TBL] [Abstract][Full Text] [Related]
11. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
12. Development of a risk prediction model for Barrett's esophagus in an Australian population.
Ireland CJ; Fielder AL; Thompson SK; Laws TA; Watson DI; Esterman A
Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881896
[TBL] [Abstract][Full Text] [Related]
13. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
14. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
[TBL] [Abstract][Full Text] [Related]
15. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study.
Ireland CJ; Thrift AP; Esterman A
Dig Dis Sci; 2020 Oct; 65(10):2992-2999. PubMed ID: 31897894
[TBL] [Abstract][Full Text] [Related]
16. Associations of Serum Adiponectin and Leptin With Barrett's Esophagus.
Greer KB; Falk GW; Bednarchik B; Li L; Chak A
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2265-72. PubMed ID: 25737442
[TBL] [Abstract][Full Text] [Related]
17. [Immunology-related aspects of gastroesophageal reflux disease and Barrett's esophagus formation].
Lipatova TE; Osadchuk MA
Eksp Klin Gastroenterol; 2006; (2):36-40, 126-7. PubMed ID: 16866263
[TBL] [Abstract][Full Text] [Related]
18. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
Brandt MG; Darling GE; Miller L
Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
Almers LM; Graham JE; Havel PJ; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
[TBL] [Abstract][Full Text] [Related]
20. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
Eisen GM; Sandler RS; Murray S; Gottfried M
Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
